|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents: | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Interest bearing time deposits in other banks | ||||||||||||||||||||
| Investment securities available-for-sale | ||||||||||||||||||||
| Investment securities held-to-maturity | ||||||||||||||||||||
| Loans, net of allowance for credit losses of $53,591 and $43,949 at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Non-marketable equity securities, at cost | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Derivative assets | ||||||||||||||||||||
| Right-of-use asset - operating leases | ||||||||||||||||||||
| Core Deposit Intangible, net | ||||||||||||||||||||
| Goodwill and other intangible assets | ||||||||||||||||||||
| Core deposit intangibles, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Lease liability - operating leases | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Line of credit - Senior Debt | ||||||||||||||||||||
| Note payable - Subordinated Debentures, net | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Series A Convertible Non-Cumulative Preferred Stock, $1 par value; 69,400 shares authorized and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, $1 par value; 50,000,000 shares authorized; 16,717,589 and 13,969,517 issued; and 16,639,127 and 13,891,055 outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Treasury stock: at cost; 78,462 shares at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
